Catalyst Wire Dossier Catalyst Wire Dossier

Aimmune Therapeutics, Inc. oral immunotherapy for hen egg allergy

· Aimmune Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aimmune Therapeutics, Inc. oral immunotherapy for hen egg allergy, covering 2022-02-28 to 2022-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy [Phase 2]

See pricing